Navigation Links
David H. Murdock Research Institute Taps Waters for Laboratory Technology

Strategic Partnership Provides Advanced Technology for Groundbreaking

Nutrition and Disease Research

KANNAPOLIS, N.C. and MILFORD, Mass., Oct. 15 /PRNewswire-FirstCall/ -- The David H. Murdock Research Institute (DHMRI), located at the North Carolina Research Campus in Kannapolis, NC, and Waters Corporation (NYSE: WAT) announced today that Waters(R) has been selected as the institute's primary supplier of analytical science solutions, including mass spectrometers, liquid chromatographs and associated scientific data management software.

"We selected Waters as a partner based on their breakthrough technologies and hands-on approach to customer service. The equipment that we've purchased from Waters is recognized as the most sophisticated laboratory equipment available," said David H. Murdock, DHMRI founder. "This large purchase continues the momentum we're building as a cutting-edge research facility sought after by some of the nation's brightest scientists, and positions us well for the future."

The new laboratory instrumentation will enable DHMRI's research programs in the areas of nutrition science and disease prevention and provide state-of the-art capabilities in proteomics research and metabolic profiling, among other key application areas

"Our respective organizations have a similar focus on pushing the limits of scientific discovery and productivity, as well as collaboration," said Art Caputo, Executive Vice President and President of the Waters Division. "As with all our partners, we are pleased to be working closely with DHMRI to help make scientific discovery at the facility possible."

Among the new mass spectrometers purchased by DHMRI are a number of Waters(R) SYNAPT(TM) High Definition Mass Spectrometers -- the first commercially-available mass spectrometer with the ability to analyze ions by their size, shape and charge in addition to mass -- as well as the Waters Quattro Premier(TM) XE and ACQUITY(R) SQD systems. DHMRI also purchased several ACQUITY UltraPerformance liquid chromatography (UPLC(R)) systems as their preferred inlet to the Institute's mass spectrometers.

About the David H. Murdock Research Institute

The David H. Murdock Research Institute was established as a public charity to support groundbreaking research at the North Carolina Research Campus. Funded through a private grant by David H. Murdock, DHMRI will host the world's top talent and resources - and promote a level of scientific collaboration never before possible. DHMRI is the first of its kind, housing a unique collection of state-of-the-art instrumentation in one central location.

For more information visit

About Waters Corporation

Waters Corporation creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.47 billion in 2007 and 5,000 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

For more information visit

Waters, ACQUITY, UPLC, Synapt, and Quattro Premier XE are trademarks of Waters Corporation.


Waters Corporation:

Brian J. Murphy



Phyllis Beaver


SOURCE Waters Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NSF International Acquires David Begg Associates
2. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
3. Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
4. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
5. Indevus Pharmaceuticals Announces Retirement of David B. Sharrock From Its Board of Directors
6. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
7. Immunosyn Corporation Names G. David Criner as CFO
8. Pasteuria Bioscience Taps New CEO David N. Duncan
9. David Mott Appointed Non Executive Director at Shire
10. Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer
11. Transgenomic Appoints David Pauluzzi to Board of Directors
Post Your Comments:
(Date:11/30/2015)... and MAGDEBURG, Germany , November 30, ... (ECNR) in Vienna, Austria to ... Congress of NeuroRehabilitation (ECNR) in Vienna, Austria ... NovaVision, a wholly owned subsidiary of Vycor Medical, Inc. ... of its Internet-delivered NovaVision Therapy Suite at the 3rd ...
(Date:11/28/2015)... ... 2015 , ... • Jeon Jin Bio Corp, a Korean Biotech venture company, ... , Bird Free, an oil-based, gel formula made ... including visual, smell, taste and touch, enabling safe, effective avian control without toxic chemicals ...
(Date:11/26/2015)... 2015 ... Research Laboratories, a leading independent and ... has formed a strategic partnership with ... Health for joint work on clinical ... ) , --> ,     ...
(Date:11/25/2015)... 25, 2015 2 nouvelles études permettent ... les différences entre les souches bactériennes retrouvées dans la ... des êtres humains . Ces recherches  ouvrent une nouvelle ... prise en charge efficace de l,un des problèmes ... chats .    --> 2 nouvelles études ...
Breaking Biology Technology:
(Date:11/17/2015)... Nov. 17, 2015 Pressure BioSciences, Inc. (OTCQB: ... development and sale of broadly enabling, pressure cycling technology ... industry, today announced it has received gross proceeds of ... Private Placement (the "Offering"), increasing the total amount raised ... more additional closings are expected in the near future. ...
(Date:11/11/2015)... Minn. , Nov. 11, 2015   MedNet Solutions ... entire spectrum of clinical research, is pleased to announce that ... in Clinical Trials (PCT) event, to be held November ... be able to view live demonstrations of iMedNet ... and learn how iMedNet has been able to ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
Breaking Biology News(10 mins):